Chlamydia trachomatis is the most commonly diagnosed sexually tra

Chlamydia trachomatis is the most commonly diagnosed sexually transmitted infection (STI) in Australia, with annual notifications having quadrupled in the last decade from 20 275 cases in 2001 to 80 724 cases in 2011.[1, 2] Although the number of cases of chlamydia diagnosed has increased in most age groups and in both males and

females, the greatest increase (almost 80%) has been in the 15–29 year age group.[1, 2] The concern with chlamydia infections is that it is most often asymptomatic in women.[3] Left untreated, persistent infection can have significant clinical consequences such as pelvic inflammatory disease, ectopic pregnancy and tubal infertility in women and epididymitis and epididymo-orchitis in men.[3-5]

For these reasons, regular testing of those that are thought to be most at risk of chlamydia is considered a key public health control strategy.[3, 6, 7] In its first Vemurafenib cost selleck compound National Sexually Transmissible Infections Strategy (NSTIS) in 2005, the Australian federal government stated that chlamydia screening programmes should be designed to specifically identify and test male and female sub-populations on the basis of risk factors.[6] This should include targeting all sexually active young people aged 15–29 years, those who have experienced inconsistent barrier contraception, those with multiple sexual partners and those with a prior diagnosed history of STIs.[6] Consequently the Australian federal government committed to improving chlamydia screening from general practice on the basis that nearly 90% of women and 70% of men aged between 15 and 29 years see their general practitioner (GP) at least once a year.[8] Although national guidelines for GPs recommend testing all sexually active people aged 15–25 years for chlamydia annually,[9] an evaluation of Medicare data for the period of October 2007 to September 2008 indicated that only 8.9% (95% confidence interval, 8.88–8.94%) of young people between the ages of 15–29 years had been tested.[10] An Australian mathematical

modelling study predicts that this percentage would have to increase to 30% among the 15–29 year age group to halve the prevalence of chlamydia in Australia Verteporfin in vitro within 4 years.[11] Australia is a long way from achieving this target and while current health services such as general practice, family planning and sexual health clinics are well equipped to treat diagnosed cases of chlamydia, there is evidently an unmet need for testing those at risk and venues other than general practice may have to be considered. The second NSTIS, released in 2009, recommended a re-orientation of health services so that young people have easy access to confidential, youth-friendly chlamydia screening sites that have late evening and weekend opening hours.

, 2007) In this study, we report a Q-PCR assay integrated with H

, 2007). In this study, we report a Q-PCR assay integrated with HRM analysis for specific rapid identification of six classical species in the Listeria genus, not including two newly

identified members. The reference strains used in this study were obtained mainly from the American Type Culture Collection (Table 1). Thirty-four L. monocytogenes and L. innocua strains (representing Ensartinib cell line various serotypes) previously isolated from foods were obtained from laboratory stock at the Zhejiang Provincial Center for Disease Control and Prevention (Table 2). All the strains were identified using standard microbiological procedures as previously described (Rossmanith et al., 2006) and then placed in Cryocare Bacterial Preservers (Key Scientific Products, Stamford, TX) and stored at −80 °C. Listeria strains were grown at 30 °C overnight in 3% tryptone soy broth plus 0.6% yeast extract (Oxoid, Hampshire, UK) (Zhang et al., 2007). All non-Listeria were cultured in Luria-Bertani medium according to individual requirements for 24–36 h (Miliotis & Bier, 2003).

The number of bacteria was calculated using a plate colony count assay. Genomic DNA was prepared using a Gentra Puregene Yeast/Bact kit (Qiagen, Valencia, CA) according to the manufacturer’s instructions. Purified genomic DNA was stored at −20 °C in Tris–ethylenediaminetetraacetic acid (TE). Artificially contaminated food samples (juice, milk, cheese and meat, which were tested as negative for Listeria species by selective plating before use) were prepared under Panobinostat molecular weight double-blind conditions by directly spiking with Listeria species, whose amount is ranged from 10 to 107 colony-forming

unit (CFU) mL−1, and the cheese and the meat were prepared according to the reference respectively (O’Grady et al., 2008). Briefly, the procedure was performed as follows: 25 mL g−1 of food samples were added to 225 mL half-Fraser medium (half the content of selective components as recommended by the manufacturer) (Oxoid) and then homogenized in a stomacher 400 homogenizer (Seward, Worthington, UK) for 2 min. Subsequently, two homogenates of PIK-5 each food were prepared; one was confirmed to be negative for Listeria species according to ISO 11290-1 (Rossmanith et al., 2006), and the other one was randomly inoculated with the described bacterial dilution under a double-blind condition. Aliquots of 1 mL of homogenates were collected and centrifuged at 5000 g for 10 min at 4 °C, and then Genomic DNA was extracted according to the reference methods (Amagliani et al., 2007). The ssrA gene encoding a transfer-messenger RNA (tmRNA) was chosen as the target. The gene sequences of L. monocytogenes (GenBank accessions AF440348, AF440347, AF440346, AF440345, AF440344, AF440343), L. welshimeri (AF440351, AM263198), L. seeligeri (AF440350, FN557490), L. ivanovii (AF440342), L. innocua (AF440341, AF440340, AF440339, AF440338, AF440337), and L. grayi (AF440349, AF440336), were obtained from GenBank.

Although abnormal frontostriatal structure and function have been

Although abnormal frontostriatal structure and function have been observed in individuals addicted to cocaine, it is less clear how individual variability in brain structure is associated with brain function to influence behavior. Our objective was to examine frontostriatal structure and neural processing of money value in chronic Trichostatin A cell line cocaine users and closely matched healthy controls. A reward task that manipulated different levels of money was used to isolate neural activity associated with money value. Gray matter volume measures were used to assess frontostriatal structure. Our results indicated that cocaine users had an abnormal money value signal in the sensorimotor striatum

(right selleck putamen/globus pallidus) that was negatively associated with accuracy adjustments to money and was more pronounced in individuals with more severe use. In parallel, group differences were also observed in both the function and gray matter volume of the ventromedial prefrontal cortex; in the cocaine users, the former was directly associated with response to money in the striatum.

These results provide strong evidence for abnormalities in the neural mechanisms of valuation in addiction and link these functional abnormalities with deficits in brain structure. In addition, as value signals represent acquired associations, their abnormal processing in the sensorimotor striatum, a region centrally implicated in habit formation, could signal disadvantageous associative learning in cocaine addiction. “
“A functional decline of brain regions underlying memory processing represents a hallmark of cognitive aging. Although a rich literature documents age-related differences in several memory domains, the effect of aging on networks that underlie multiple memory processes has been check details relatively unexplored. Here we used functional magnetic resonance imaging during working memory and incidental episodic encoding memory to investigate patterns of age-related

differences in activity and functional covariance patterns common across multiple memory domains. Relative to younger subjects, older subjects showed increased activation in left dorso-lateral prefrontal cortex along with decreased deactivation in the posterior cingulate. Older subjects showed greater functional covariance during both memory tasks in a set of regions that included a positive prefronto-parietal-occipital network as well as a negative network that spanned the default mode regions. These findings suggest that the memory process-invariant recruitment of brain regions within prefronto-parietal-occipital network increases with aging. Our results are in line with the dedifferentiation hypothesis of neurocognitive aging, thereby suggesting a decreased specialization of the brain networks supporting different memory networks.

In pregnant women who require therapy for their own health, HAART

In pregnant women who require therapy for their own health, HAART is always advised. There remains a lack of consensus regarding optimum obstetric management of pregnant HIV-infected women in the HAART era. As a result of very low

MTCT rates under effective HAART [1–4], the additional value of selleck screening library an elective CS for PMTCT has been questioned in cases where the HIV RNA load is below detection (usually <40–50 HIV-1 RNA copies/mL). Concerns relate to the risk–benefit balance of elective CS in such circumstances, particularly as HIV-infected women may be more likely to experience postnatal complications than uninfected women, and that women delivering by elective CS are more likely to have complications than those delivering vaginally [20,21]. Some guidelines still recommend an elective CS for women on HAART with undetectable HIV RNA loads [15,16], whereas other guidelines no longer do so [13,14,17,19,22]. In the case of a measurable pre-labour HIV RNA load an elective CS is generally recommended. Our objectives were selleck kinase inhibitor to examine temporal and geographical patterns of mode

of delivery in the Western European centres of the European Collaborative Study (ECS), to identify factors associated with likelihood of elective CS delivery in the HAART era and to explore the associations between mode of delivery and MTCT. The ECS is a birth cohort study, established in 1986, in which HIV-infected women are enrolled during pregnancy and their infants prospectively followed according to standard protocols not [2,23]. The analyses presented here are limited to mother–child pairs (MCPs) enrolled

from the eight participating Western European countries up to the end of 2007. All pregnant women are offered antenatal HIV testing, and those infected invited to participate; pregnant women already known to be HIV-infected on the basis of earlier testing are also invited to take part. Informed consent is obtained before enrolment, according to local guidelines, and local ethics approval has been granted. Information collected at enrolment and during pregnancy includes current antiretroviral treatment (ART), maternal immunological and virological status and mode of acquisition. Maternal CD4 cell counts have been routinely collected since 1992 and HIV RNA measurements from 1998. Laboratory tests were performed locally; all laboratories were based in tertiary care hospitals. Maternal CD4 cell count and HIV RNA level nearest to delivery were used in the analyses. CD4 counts were categorized as <200, 200–499, and ≥500 cells/μL.

, buy JQ1<

, ABT-263 purchase 2005; Militello et al., 2008). Briefly, isolated E. coli DNA (1 μg) from overnight cultures was digested to nucleosides using sequential treatment with S1 nuclease, snake venom phosphodiesterase, and alkaline phosphatase before separation on a dC18 column. Tandem mass spectrometry was used to detect the molecular ion (242.1 atomic mass units) and product ion (126.3 atomic mass units) for 5mdC. Simultaneously, the molecular

ion and product ion for 2′-deoxyguanosine were detected. The ratios of 5mdC to 2′-deoxyguanosine in the experimental samples were compared to a standard curve of the same two nucleosides, to generate percent 5mdC. At least three distinct biological samples Caspase pathway (separate cultures) were used for each strain, except for the commercial E. coli B preparation (four technical replicates). Overnight E. coli cultures were diluted 1 : 100 into fresh LB medium and grown at 37 °C

until early logarithmic phase (OD600 nm of ~0.4) and early stationary phase (OD600 nm of ~3.0). Total RNA was isolated using the MasterPure RNA Isolation kit (Epicentre). cDNA was made from 2 to 3 μg of RNA in presence of random primers. qPCR was performed on a Stratagene Mx3000P machine with Stratagene Brilliant Sybr Green qPCR master mix. Primer sequences are found in Fig. S1. Reactions were performed in triplicate and at least two different RNA samples were tested (biological replicates). A PCR assay was developed to detect the presence of the dcm gene in E. coli. Forty-one E. coli and Shigella full-length dcm DNA sequences were obtained from NCBI (http://www.ncbi.nlm.nih.gov/genomes/lproks.cgi). Decitabine ic50 The sequences were aligned using ClustalX 2.0.10 (www.clustal.org/) and used to construct a N-J tree (Fig. S2). To develop a set of PCR primers for the full-length gene (1419 basepairs), the sequences at the beginning and the end of the alignment were examined. The first 88 nucleotides of all gene sequences were identical, and one forward primer was chosen. While there are three possible reverse primers, reverse primer III is present

in only one sequence, and we therefore used a mixture of reverse primers I and II for all experiments. Initial PCRs were optimized using E. coli JM109 DNA (dcm+) as a positive control, and the reactions routinely generated a product of the expected size of 1419 basepairs (Fig. 1a). The assay was specific, as the dcm PCR product was not observed in reactions without DNA template or with DNA from E. coli GM204, a strain with a deletion of the dcm operon. To confirm that the PCR product truly represented the dcm gene, the PCR DNA from E. coli JM109 was purified and analyzed by DNA sequencing (data not shown). Subsequently, we used the PCR assay to screen the E. coli strains from multiple sources.

, 2012) Ammonium, nitrite, and nitrate were extracted from the s

, 2012). Ammonium, nitrite, and nitrate were extracted from the soil with 2 M KCl and measured using a SAN++ Continuous Flow Analyzer (Skalar Analytical, The Netherlands). Total nitrogen, soil organic matter, Mn2+, and Mn4+ were measured according to standard methods (Bao, 2000). Soil pH was determined at a soil/water ratio of 1 : 2.5. All analyses were performed in triplicate on each sample. The in situ measurement of oxygen concentration was achieved by OXY Meter S/N 4164 with stainless electrode sensor (Unisense, Denmark) (Gundersen et al., 1998). Statistical analyses were performed using program spss for Windows. DNA in soil and sediment samples were extracted

from 0.25 g PI3K inhibitor samples using the Powersoil DNA isolation kits (Mobio). DNA from enriched anammox biomass was extracted according to the method described previously (Schmid et al., cancer metabolism inhibitor 2008). For the specific PCR amplification of the anammox hzsB gene,

newly designed primer pair of hzsB_396F and hzsB_742R was applied based on our new findings in anammox molecular mechanism (Kartal et al., 2011; Harhangi et al., 2012). The pmoA gene of n-damo bacteria was amplified using a nested approach (first-step primer pair A189_b-cmo682, followed by primer pair cmo182-cmo568) according to Luesken et al. (2011c). The 16S rRNA gene of n-damo was amplified using a nested approach (first-step primer pair 202F-1545R, followed by primer pair qP1F-qP2R) according to Juretschko et al. (1998) and Ettwig et al. (2009). The sequences of primers and thermal profiles were shown in Table 1. PCRs

were performed with the PerfeCTa SYBR Green FastMix (Quanta). 10 min at 95 °C, followed by 35 cycles of 60 s at 95 °C, 60 s at 59 °C and 45 sat 72 °C (PCR) 3 min at 95 °C, followed by 40 cycles of 30 s at 95 °C, 30 s at 59 °C and 30 sat 72 °C (qPCR) 10 min at 95 °C, followed by30 cycles of 60 s at 95 °C, 60 s at 63 °C and 45 sat 72 °C (PCR, qP1F – qP2R) 3 min at 95 °C, followed Cyclic nucleotide phosphodiesterase by 40 cycles of 30 s at 95 °C, 30 s at 63 °C and 30 sat 72 °C (qPCR, qP1F – qP1R) PCR amplified fragments were cloned using the pGEM-T Easy cloning kit (Promega) according to the manufacturer’s instructions. Plasmid DNA was isolated with the GeneJET Plasmid Miniprep kit (Fermentas, Lithuania). Plasmids were digested with EcoRI enzyme, and the digestion products were examined for an insert with expected size by agarose (1%) gel electrophoresis. Selected clones were sequenced using primer of M13f targeting vector sequences adjacent to the multiple cloning sites. Phylogenetic analysis was performed using mega 5.0 software (Tamura et al., 2011) by neighbor-joining (NJ) with the Jukes-Cantor correction. Diversity indices, including Chaol, Shannon, and Simpson, were generated by DOTUR for each clone library (Schloss & Handelsman, 2005). Quantitative PCR was performed on a Bio-Rad iQ5 real-time PCR instrument (Bio-Rad) with a SYBR Green qPCR kit (Quanta).

MICs of TGC (MICTGC) were interpreted as per the US Food and Drug

MICs of TGC (MICTGC) were interpreted as per the US Food and Drug Administration’s breakpoint recommendations for Enterobacteriaceae. MICs of RIF (MICRIF) and AZT (MICAZT) were interpreted using CLSI breakpoints for Haemophilus influenzae (Clinical & Laboratory Standards Institute, 2009). The test was conducted in triplicate. Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 strains were used as controls. Of the 33 strains from the susceptibility testing, 13 clone A strains and seven clone click here B strains were randomly chosen for the in vitro testing of the following combinations using Etest: IMP–RIF, IMP–COL,

IMP–DOX, IMP–AN, IMP–AZT, COL–RIF, COL–DOX, COL–AN, COL–TGC, TGC–AN, and TGC–AZT. Two strips, one containing antibiotic A and another containing antibiotic B, were aligned at 90° at the respective MIC (mg L−1) of two antibiotics, MICA and MICB, as previously described (White et al., 1996). To evaluate interactions between antibiotics, the fractional inhibitory concentration (FIC) and FIC index were calculated as previously described (White et al., 1996; Tascini et al., 1998; Timurkaynak et al., 2006; Tan et al., 2007). Antibiotic combinations were evaluated based on the FIC index, which ranges as follows: synergistic if ≤ 0.5; additive Sirolimus in vivo if > 0.5 but < 1; indifferent if ≥ 1 but < 4; and antagonistic

if ≥ 4. The effect of adding RIF on the mean MICs of IMP (MICIMP) and of COL (MICCOL) for the same 20 strains was analyzed using two-tailed paired t-test with 95% confidence interval. The tests were performed in duplicate, with additional tests performed until two identical results were selected as confirmed. No fifth test was required. Three clone A strains and two clone B strains from the in vitro testing of antimicrobial combinations were analyzed using analytical Nintedanib (BIBF 1120) isoelectric focusing (aIEF) as previously described (Paterson et al., 2001). These strains

had different MICs of IMP, AN, AZT, COL, DOX, RIF, and TGC. Using PCR we screened for β-lactamase genes (blaTEM, blaSHV, blaPER, blaADC, blaIMP, blaVIM, blaOXA-23,blaOXA-Ab, and blaOXA-58) and genes encoding AMEs (aphA6, aadA1, aadB, aacC1, and aacC2). Additional determinants included integrase genes (intII, intI2 and intI3); disruptions in the outer membrane protein gene, carO; and the presence of adeR. We also examined the mutations in QRDRs of gyrA and parC by direct sequencing of the PCR products. All determinants were PCR-amplified using established primers and controls previously described (Hujer et al., 2006). According to our medical record review, of 121 MDR A. baumannii strains, 102 were hospital-acquired. Based on rep-PCR, 76 belonged to a major clone A and eight to a minor clone B. The study strains’ clonality, sources, and antimicrobial susceptibility data based on VITEK 2 are summarized in Supporting Information, Table S1.

, Gaithersburg, Washington DC, USA) Serum samples were used for

, Gaithersburg, Washington DC, USA). Serum samples were used for (1) HIV 1 and 2 antigens and antibodies by the Combo Assay on the Architect Immunoassay Platform and (2) syphilis by the RPR-nosticon II kit (Biomerieux, Boxtel, the Netherlands). Samples with positive screening results were confirmed for (1) HIV by the western blot assay and (2) syphilis (RPR) by Serodia-TP TPPA (Fujirebio Inc., Tokyo, Japan). The results were given to the patients within 2 to 4 weeks, either through a face-to-face interview or if negative, through a telephone consultation after the patient identity code was checked. A follow-up medical

consultation was arranged and treatment was given based on the Department of Health’s STI management guidelines (except for HIV due to the high cost) for positive cases. Patients Apoptosis inhibitor with syphilis were referred to a SHC or private specialist for further follow-up treatment, as were those patients who indicated a preference for such an option. The patients’ official travel documents were not checked to access this service so that their privacy and confidentiality was ensured. Demographic and sexual behavior characteristics were compared by place of origin of FSW, as a previous study showed that this variable carries a significant difference in the development of abnormal Ku-0059436 mw Papanicolau (PAP) smears (a proxy measure of human papillomavirus).13 For nominal characteristics, Pearson’s

chi-square test or, for small samples, Fisher’s exact test was used (Monte-Carlo sampling Etofibrate methods were used to estimate the p values). For continuous characteristics, the Kruskal–Wallis test was used. The groupings for place of origin were local women; new migrants holding a Hong

Kong Identity Card and having right of abode; and visitor FSW who were visiting from Mainland China on a tourist visa. Logistic regression was used to look for risk factors of STI/HIV after controlling for age, education, smoking, and alcohol drinking as confounders. Ethics approval was obtained from the Joint Chinese University of Hong Kong and the New Territory East Cluster Clinical Research Ethical Committee. A total of 503 of 511 (98.4%) FSW, new attendees to the clinic had a complete set of questionnaires and investigations during December 2005 and April 2007. Table 1 shows their personal and family characteristics. Although they were all Chinese in ethnicity, 97 (19.3%) participants were local Chinese, 361 (71.8%) were new migrants, and 45 (8.9%) were illegal migrant workers. Inter-group comparisons showed that significant differences existed in some demographic characteristics, namely age (p < 0.01), marital status (p < 0.01), number of children in family (p < 0.01), and alcohol (p = 0.05) or smoking habits (p < 0.01), in that the local FSW tended to be older and more likely to smoke but the newly migrant and visitor FSW were more likely to have dependent children.

Technology should therefore be used to link the three partners (p

Technology should therefore be used to link the three partners (patient, pharmacist, GP), with each having different responsibilities. In such an approach the patient will be responsible for managing their medicines according to an agreed schedule, carrying

out the home monitoring and providing feedback on symptom control through the connected health equipment. The results of this engagement will then be relayed (wirelessly or via landline linkage) to a central (web-based) data platform, which will automatically send back a positive, supportive message to the patient if control is being achieved. When disease management markers become out of control, they will automatically trigger an alert message to be sent to the patient and also to the GP or pharmacist (or both) for appropriate action to be taken. Having reviewed www.selleckchem.com/products/LY294002.html the findings, the GP or pharmacist

could then send a text message to the home base unit or telephone the patient to give advice. This type of approach could also be delivered from a hospital base (hospital doctor and clinical pharmacist), for example, during the first month (highest risk period for readmission) after a patient has been hospitalised, before ‘discharging’ the patient to the primary care providers when the patient is deemed to be stabilised. This ‘ward in the community’ concept could be a useful approach to addressing high readmission rates. Continued support could be provided from the hospital pharmacy team if community pharmacists do not wish to become engaged. There are some examples of pharmacist EMD 1214063 engagement in

‘connected health’ in published studies to date, however, these have been the exception. Although a recent study in the New England Journal of Medicine (evaluating a telemonitoring programme for heart failure patients) provided no evidence of benefit, further research is urgently required within this ‘space’ as Reverse transcriptase monitoring equipment becomes more sophisticated and user friendly. It is clear that not all patients will have the required self-efficacy to fully participate in this type of programme, or may have issues around privacy, and a test of suitability may need to be developed, in much the same way as a genomics test is used in personalised medicine. This would allow alternate approaches to care provision to be considered and help prevent unnecessary spend on equipment that will remain unused. It is clear that further rapid developments will be made in the connected health world in the near future. Pharmacists must become engaged or find themselves further excluded from the care of patients with chronic illness and pharmacy practice researchers must assist by providing the evidence base for this new paradigm in chronic disease management.

Technical support issues arising from supporting information (oth

Technical support issues arising from supporting information (other than missing files) should be addressed to the authors. “
“The substantia nigra pars reticulata (SNr) is thought to serve as the output of the basal ganglia, whereby associative information from striatum Idasanutlin solubility dmso influences behavior via disinhibition of downstream motor areas to motivate behavior. Unfortunately, few studies have examined activity in SNr in rats making decisions based on the value of predicted reward similar to those conducted in primates. To fill this void, we recorded from single neurons in SNr while rats performed a choice

task in which different odor cues indicated what reward was available on the left or on the right. The value of reward associated with a leftward or rightward movement was manipulated by varying the size of and delay to reward in separate blocks of trials. Rats were faster or slower depending

on whether the expected reward value was high or low, respectively. The number of neurons that increased firing during performance of the task outnumbered those that decreased firing. Both increases and decreases were modulated by expected value and response direction. Neurons that fired more or less strongly for larger reward tended to fire, respectively, more or less strongly for immediate reward, reflecting selleck chemicals llc their common motivational output. Finally, value selectivity was present prior to presentation of cues indicating the nature of the upcoming behavioral response for both increasing- and decreasing-type neurons, reflecting the internal bias or preparatory set of the rat. These results emphasize the importance of increasing-type neurons on behavioral output when animals are making decisions based on predicted reward value. “
“A previous analysis of the quinpirole sensitisation rat model of obsessive-compulsive disorder revealed that the behavioral phenotype of compulsive checking consists of three constitutive components

– vigor of checking performance, focus on the task of checking, and satiety following a bout of Thalidomide checking. As confirmation of this analysis, the aim of the present study was to reconstitute, without quinpirole treatment, each of the putative components, with the expectation that these would self-assemble into compulsive checking. To reconstitute vigor and satiety, the employed treatment was a bilateral lesion of the nucleus accumbens core (NAc), as this treatment was shown previously to exaggerate these components. To reconstitute focus, the employed treatment was a low dose of the serotonin-1A receptor agonist 8-hydroxy-2-(di-n-propylamino) tetralin hydrochloride (DPAT) (0.0625 mg/kg), as high doses of this drug induce compulsive behavior and exacerbate focus. Results showed that injection of DPAT to NAc lesion rats did yield compulsive checking. Neither the drug alone nor the NAc lesion by itself produced compulsive checking.